Rhupus Syndrome and Efficacy of Etanercept Treatment
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
between March 2013 and March 2014, Rhupus patients were enrolled to receive a 25-mg
etanercept injection subcutaneously twice a week. The follow-up time of the study was 24
weeks.